Abstract. A new, simple experimental endometriosis model was established by auto
Abstract. A new, simple experimental endometriosis model was established by auto-transplanting endometrial tissue fragments beneath kidney capsules in female rats. The transplanted endometrial tissue grew well, forming a fluid-filled cyst, which reached maximal size 2 to 3 weeks after transplantation.
The growth and maintenance of the transplants was dependent on the ovary: ovariectomy induced regression of well grown transplants. The therapeutic effects of TAP-144-SR (biodegradable microcapsules of copoly (DL-lactic/glycolic acid) copolymer containing a potent GnRH agonist, TAP-144 (D-Leu6-[des-Gly-NH2]-GnRH ethylamide, leuprolide acetate) were studied with this rat endometriosis model. A single sc injection of TAP-144-SR (corresponding to 1, 10 ENDOMETRIOSIS is one of the most common diseases among women in their thirties and forties. Animal models of endometriosis have been reported with rabbits [1, 2] , monkeys [3] and rats [4] . For evaluation of the therapeutic potential of GnRH agonists, an animal model of endometriosis with rats is most suitable because of the high sensitivity of these animals to GnRH agonists [5, 6] and practical considerations. However, we experienced problems with the procedure in explanting endometrial tissue into the peritoneal cavity according to the method of Jones [4] . Inconsistent growth of the transplants and attachment of fat tissue to them resulted in a low yield of usable animals. We then tried auto-transplanting endometrial tissue fragments under the kidney capsules of female rats and succeeded in establishing a simple endometriosis model. Potent GnRH agonists have been reported to downregulate the gonadal functions in chronic treatment of pharmacological doses and this paradoxical effect has been clinically utilized in treating a variety of hormonally responsive clinical disorders [7, 8] . The paradoxical effects of GnRH agonists are thought to be mainly due to desensitization of the pituitary and gonads [9] . Recently, biodegradable microcapsules of copoly (DLlactic/glycolic acid)(PLGA) copolymer containing a potent GnRH agonist, TAP-144 (leuprolide acetate, (D-Leu6-[des-Gly 10-N H2]-GnRH ethylamide acetate; [10, 11] were developed with a view to maintaining a constant release for 1 month [ 12, SUDO et al. 13 ]. Administration of TAP-144-SR has been shown to decrease the testosterone concentration and prostate weight in male rats and dogs [14] and to decrease serum estradiol in female rats [13, 15] . Besides the advantage of reducing the frequency of injections, maintaining constant TAP-144 levels in serum by TAP-144-SR administration may affect the potency of the paradoxical effects of the GnRH agonist.
In the present study, the therapeutic effects of TAP-144-SR were examined by means of our new simple endometriosis model in rats. The therapeutic effectiveness of TAP-144-SR was compared with that of TAP-144 adminstered as a solution.
Materials and Methods
Animals and treatment TAP-144-SR was prepared by suspending TAP-144-containing microcapsules of PLGA copolymer in 2.5ml/kg of suspension vehicle. The concentration of TAP-144 in the microcapsules was 8%. The method for preparing TAP-144-containing microcapsules has been described elsewhere [ 12] . The daily equivalent dose was calculated by dividing the injected dose by 30. The TAP-144 solution was made up in 1ml/kg of saline. Rats were injected sc with either TAP-144 solution or TAP-144-SR. Radioimmunoassay Serum concentrations of LH and FSH were determined by a double antibody radioimmunoassay with NIADDK rat RIA kits [ 16] . Purified LH (NIADDK-rat LH-I-7) and FSH (NIAMDD-rat FSH-I-4) were labeled with 1251 (125I-NaI, New England Nuclear, Du Pont) according to the chloramine-T method of Greenwood et al. [17] . Serum levels of LH and FSH were expressed in terms of NIAMDD-rat LH-RP-1 and NIAMDDrat FSH-RP-1, respectively. exhibited a statistically significant difference. Thus, it is likely that the efficacy of the 2 dosage forms in suppressing transplant growth also differs without statistical significance due to great variation from animal to animal. These results indicate that at the highest dose, the sustainedrelease formulation of TAP-144 is more effective than TAP-144 solution in suppressing ovarian hormone-dependent tissue growth. TAP-144-SR is also more effective than TAP-144 solution in suppressing testicular hormone-dependent accessory sex organ weight in male rats [19] . The reason why TAP-144-SR is more efficient than TAP-144 solution at the highest dose, and the reverse is true at the lowest dose may be explained as follows. The lowest dose of TAP-144-SR may give a constant, but an insufficient serum concentration of TAP-144 to exhibit pharmacological actions. In contrast, TAP-144 solution can give a transient, but sufficient serum concentratin of TAP-144 to exhibit pharmacological actions. This is the reason why TAP-144 solution is more efficient than TAP-144-SR at the lowest dose. At the highest dose, maintaining a constant concentratin of TAP-144 with TAP-144-SR may be more effective for desensitization, which requires long-term occupancy of target cells.
The effects of TAP-144 administration on the serum and pituitary concentrations of gonadotropins and ovarian weight for the two dosage formulations were different; administration of the solution increased the serum LH and FSH concentrations and ovarian weight, and decreased the pituitary LH concentration, whereas the administration of TAP-144-SR decreased the serum FSH, pituitary LH and FSH concentrations and ovarian weight. This discrepancy in the effects of the two dosage formulations on gonadotropin levels has also been observed in male rats [19] . Pituitary concentrations of LH and FSH are also lower in TAP-144-SR-treated than in TAP-144-solutiontreated male rats. Desensitization of the gonads is usually associated with high serum concentrations [9] . Although serum LH concentrations in TAP-144-SR-treated rats are not higher than those in the control rats, the desensitization might have been induced by high serum concentrations of LH shortly after the TAP-144-SR treatment [ 15] . Additionally, the desensitization may continue as long as serum TAP-144 concentrations are maintained at levels sufficient to stimulate the pituitary.
In fact, TAP-144-SR-treated rats produce very little testosterone upon hCG treatment [15] . Also, other factors such as a decrease in bioactive gonadotropins and/or continued direct inhibitory action on the gonads [5, 6, 9] , may be involved in the paradoxical effects. The results of this study suggest that the effects of GnRH agonists on gonadotropins vary according to the dosage form, doses and duration of treatment; the relative importance of mechanisms through which desensitization is induced also varies according to these factors.
